{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T18:10:25Z","timestamp":1716142225864},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,19]]},"DOI":"10.7759\/cureus.60612","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T17:35:10Z","timestamp":1716140110000},"source":"Crossref","is-referenced-by-count":0,"title":["Uncovering the Diagnostic Challenge of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Case Study of Acute Bilateral Vision Loss"],"prefix":"10.7759","author":[{"given":"Anandu M","family":"Anto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Vishnu Vardhan","family":"Allu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samrachana","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trupti","family":"Vakde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eghosa","family":"Omoregi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl M","year":"2013","unstructured":"Reindl M, Di Pauli F, Rost\u00e1sy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013, 9:455-61. 10.1038\/nrneurol.2013.118","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo A","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E, et al.. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. 2018, 90:e1858-69. 10.1212\/WNL.0000000000005560","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1260358","article-title":"Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide","volume":"14","author":"Hor JY","year":"2023","unstructured":"Hor JY, Fujihara K. Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol. 2023, 14:1260358. 10.3389\/fneur.2023.1260358","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk M","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, et al.. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017, 140:3128-38. 10.1093\/brain\/awx276","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga AS","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Majed M, Fryer J, et al.. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol. 2018, 75:1355-63. 10.1001\/jamaneurol.2018.1814","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier R","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, et al.. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021, 20: P762-72. 10.1016\/S1474-4422(21)00218-0","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010100","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, Diagnosis and Management","volume":"22","author":"Ambrosius W","year":"2020","unstructured":"Ambrosius W, Michalak S, Kozubski W, Kalinowska A. Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, Diagnosis and Management. Int J Mol Sci. 2020, 22:100. 10.3390\/ijms22010100","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/pl00012510","article-title":"Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration","volume":"59","author":"Quarles RH","year":"2002","unstructured":"Quarles RH. Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration. Cell Mol Life Sci. 2002, 59:1851-71. 10.1007\/pl00012510","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato DK","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, et al.. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurol. 2014, 82:474-81. 10.1212\/WNL.0000000000000101","journal-title":"Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325121","article-title":"Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS","volume":"4","author":"Banks SA","year":"2020","unstructured":"Banks SA, Morris PP, Chen JJ, et al.. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. 2020, 4:384-90. 10.1136\/jnnp-2020-325121","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim SM","year":"2015","unstructured":"Kim SM, Woodhall MR, Kim JS, et al.. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm. 2015, 2:e163. 10.1212\/NXI.0000000000000163","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan S","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH, et al.. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016, 22:470-82. 10.1177\/1352458515593406","journal-title":"Mult Scler"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315998","article-title":"Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases","volume":"88","author":"Hyun JW","year":"2017","unstructured":"Hyun JW, Woodhall MR, Kim SH, et al.. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry. 2017, 88:811-7. 10.1136\/jnnp-2017-315998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey D","year":"2019","unstructured":"Dubey D, Pittock SJ, Krecke KN, et al.. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019, 76:301-9. 10.1001\/jamaneurol.2018.4053","journal-title":"JAMA Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi E","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, et al.. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022, 13:885218. 10.3389\/fneur.2022.885218","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.81","article-title":"Optic neuritis","volume":"25","author":"Pau D","year":"2011","unstructured":"Pau D, Al Zubidi N, Yalamanchili S, Plant GT, Lee AG. Optic neuritis. Eye (Lond). 2011, 25:833-42. 10.1038\/eye.2011.81","journal-title":"Eye (Lond)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/1874364101206010065","article-title":"Optic neuritis, its differential diagnosis and management","volume":"6","author":"Hoorbakht H","year":"2012","unstructured":"Hoorbakht H, Bagherkashi F. Optic neuritis, its differential diagnosis and management. Open Ophthalmol J. 2012, 6:65-72. 10.2174\/1874364101206010065","journal-title":"Open Ophthalmol J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius S","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, et al.. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation. 2012, 9:14. 10.1186\/1742-2094-9-14","journal-title":"J Neuroinflammation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25909","article-title":"Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"89","author":"Cobo-Calvo A","year":"2021","unstructured":"Cobo-Calvo A, Ruiz A, Rollot F, et al.. Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol. 2021, 89:30-41. 10.1002\/ana.25909","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42780","article-title":"Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom","volume":"5","author":"Satukijchai C","year":"2022","unstructured":"Satukijchai C, Mariano R, Messina S, et al.. Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom. JAMA Netw Open. 2022, 5:e2142780. 10.1001\/jamanetworkopen.2021.42780","journal-title":"JAMA Netw Open"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1756285611398702","article-title":"Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis","volume":"4","author":"Voss E","year":"2011","unstructured":"Voss E, Raab P, Trebst C, Stangel M. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011, 4:123-34. 10.1177\/1756285611398702","journal-title":"Ther Adv Neurol Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1137998","article-title":"Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease","volume":"14","author":"Corbali O","year":"2023","unstructured":"Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol. 2023, 14:1137998. 10.3389\/fneur.2023.1137998","journal-title":"Front Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.05.013","article-title":"Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis","volume":"355","author":"Mealy MA","year":"2015","unstructured":"Mealy MA, Whetstone A, Orman G, Izbudak I, Calabresi PA, Levy M. Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci. 2015, 355:59-63. 10.1016\/j.jns.2015.05.013","journal-title":"J Neurol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou K","year":"2015","unstructured":"Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC. Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Neuroimmunol & Neuroinflamm. 2015, 2:e131. 10.1212\/NXI.0000000000000131","journal-title":"Neuroimmunol & Neuroinflamm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.000000000000022","article-title":"Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus","volume":"3","author":"Sep\u00falveda M","year":"2016","unstructured":"Sep\u00falveda M, Armangu\u00e9 T, Sola-Valls N, et al.. Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus. Neuroimmunol & Neuroinflamm. 2016, 3:e225. 10.1212\/NXI.000000000000022","journal-title":"Neuroimmunol & Neuroinflamm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/252495-uncovering-the-diagnostic-challenge-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-a-case-study-of-acute-bilateral-vision-loss","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T17:35:14Z","timestamp":1716140114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/252495-uncovering-the-diagnostic-challenge-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-a-case-study-of-acute-bilateral-vision-loss"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,19]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.60612","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,19]]}}}